Walgreens Boots Alliance (NASDAQ:WBA) was downgraded by research analysts at Citigroup from a “buy” rating to a “neutral” rating in a report issued on Monday, The Fly reports.
Other equities analysts have also issued reports about the company. Pivotal Research reduced their price objective on Walgreens Boots Alliance from $73.00 to $69.00 and set a “hold” rating on the stock in a research report on Friday, March 23rd. Loop Capital increased their price objective on Walgreens Boots Alliance to $80.00 and gave the company a “buy” rating in a research report on Friday, June 29th. Leerink Swann reduced their price objective on Walgreens Boots Alliance from $75.00 to $70.00 and set a “market perform” rating on the stock in a research report on Wednesday, May 23rd. Jefferies Financial Group set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, April 3rd. Finally, BidaskClub lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, May 8th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $78.47.
Shares of WBA opened at $63.30 on Monday. The stock has a market cap of $62.82 billion, a P/E ratio of 12.41, a P/E/G ratio of 1.04 and a beta of 1.12. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.47 and a current ratio of 0.93. Walgreens Boots Alliance has a 52-week low of $59.07 and a 52-week high of $83.89.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.06. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The firm had revenue of $34.33 billion for the quarter, compared to analysts’ expectations of $34.15 billion. During the same quarter last year, the firm posted $1.33 EPS. The company’s revenue was up 14.0% compared to the same quarter last year. research analysts expect that Walgreens Boots Alliance will post 5.97 EPS for the current year.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total value of $179,372.16. Following the completion of the sale, the director now owns 13,679 shares of the company’s stock, valued at approximately $896,795.24. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 14.80% of the stock is currently owned by company insiders.
Institutional investors and hedge funds have recently modified their holdings of the stock. Caisse DE Depot ET Placement DU Quebec grew its holdings in Walgreens Boots Alliance by 32.1% during the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 9,966,798 shares of the pharmacy operator’s stock valued at $652,526,000 after purchasing an additional 2,419,053 shares during the period. CI Global Investments Inc. grew its holdings in Walgreens Boots Alliance by 2.7% during the first quarter. CI Global Investments Inc. now owns 8,124,379 shares of the pharmacy operator’s stock valued at $531,903,000 after purchasing an additional 217,119 shares during the period. LSV Asset Management grew its holdings in Walgreens Boots Alliance by 101.9% during the first quarter. LSV Asset Management now owns 7,426,687 shares of the pharmacy operator’s stock valued at $486,225,000 after purchasing an additional 3,747,907 shares during the period. Dimensional Fund Advisors LP grew its holdings in Walgreens Boots Alliance by 4.6% during the first quarter. Dimensional Fund Advisors LP now owns 6,995,071 shares of the pharmacy operator’s stock valued at $457,967,000 after purchasing an additional 305,397 shares during the period. Finally, Burgundy Asset Management Ltd. grew its holdings in Walgreens Boots Alliance by 12.3% during the first quarter. Burgundy Asset Management Ltd. now owns 6,175,133 shares of the pharmacy operator’s stock valued at $404,286,000 after purchasing an additional 675,940 shares during the period. 60.27% of the stock is owned by institutional investors.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.